PeterLabs Holdings Berhad (KLSE: PLABS)
Health Care · Pharmaceuticals · MY
RM0.23
+2.27% today · -10.0% 1Y
PeterLabs Holdings Berhad (KLSE: PLABS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.16M.
Over the last twelve months the share price has lost 10.0%, trading between 0.10 and 0.28.
Tweenvest scores PeterLabs Holdings Berhad across four factors: quality 72/100, value 65/100, growth 12/100. Its strongest factor is quality.
PLABS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.16M
- Revenue (TTM)
- $26.36M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- RM0.28
- 52-week low
- RM0.10
- Avg volume (3M)
- —
- Shares outstanding
- 275.21M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Peak Processing LimitedASX: PKP | $15.83M | AU$0.02 | +6.25% |
| Otsuka Pakistan LimitedKASE: OTSU | $15.72M | PKRs359.78 | +0.79% |
| Bal Pharma LimitedBSE: 524824 | $15.32M | Rs93.15 | -11.79% |
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
Figures last refreshed Oct 11, 2026.